Bridgefront Capital, LLC Mersana Therapeutics, Inc. Transaction History

Bridgefront Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.74 - $6.63 $58,426 - $103,573	-15,622 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$5.48 - $9.86 $85,608 - $154,032	15,622 New	15,622 $97,000
Q3 2021 Nov 12, 2021	SELL	$8.56 - $14.47 $96,180 - $162,584	-11,236 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$13.28 - $18.07 $149,214 - $203,034	11,236 New	11,236 $153,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.